|Articles|March 16, 2023

Previewing Dermatology Times Editorial Advisory Board Member Sessions at AAD 2023

Author(s)Emma Andrus, Assistant Editor

Among the more than 300 sessions to be held at this week's American Academy of Dermatology meeting in New Orleans, Louisiana, several Dermatology Times® Editorial Advisory Board members are preparing to share their knowledge and insights.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe

Related Content

Referral Barriers Persist in Advanced Cutaneous Squamous Cell Carcinoma Care

ByKaitlyn Bader, Assistant Managing Editor

July 21st 2026

Derm Dispatch: New ICD-10 Code Brings Validation to Patients With Topical Steroid Withdrawal

ByRenata Block, DMSc, MMS, PA-C,Kelly Barta,Kaitlyn Bader, Assistant Managing Editor

July 21st 2026

EADV Review Finds Major Safety and Transparency Gaps in Mobile AI Dermatology Apps

ByMarie Bosslett, Assistant Editor

July 21st 2026

Switching from Biologics to Upadacitinib Yields Progressive Improvements in Moderate to Severe AD

ByMarie Bosslett, Assistant Editor

July 21st 2026

How Dermatologists Can Incorporate GLP-1 Receptor Agonists Into Psoriasis Care

ByShannon Heaning, Content Associate

July 21st 2026

Latest CME

Video

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Andrew Alexis, MD, MPH; Leon Kircik, MD

Video

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Johann Gudjonsson, MD, PhD; Christopher Bunick, MD, PhD

Video

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Andrew F. Alexis, MD, MPH; Chesahna Kindred, MD, MBA, FAAD

Multimedia

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Jerry Bagel, MD, MS

Video

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Douglas DiRuggiero, DMSc, MHS, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP

Video

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hadar Lev-Tov, MD; Martina Porter, MD

Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Previewing Dermatology Times Editorial Advisory Board Member Sessions at AAD 2023

Related Content

Referral Barriers Persist in Advanced Cutaneous Squamous Cell Carcinoma Care

Derm Dispatch: New ICD-10 Code Brings Validation to Patients With Topical Steroid Withdrawal

EADV Review Finds Major Safety and Transparency Gaps in Mobile AI Dermatology Apps

Switching from Biologics to Upadacitinib Yields Progressive Improvements in Moderate to Severe AD

How Dermatologists Can Incorporate GLP-1 Receptor Agonists Into Psoriasis Care

Latest CME

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Trending on Dermatology Times

Switching from Biologics to Upadacitinib Yields Progressive Improvements in Moderate to Severe AD

Real-World Study Finds Experienced Dermatologists Outperform AI in Skin Cancer Diagnosis

New Consensus Defines Remission, Disease Activity in Atopic Dermatitis

Systemic JAK Inhibitors for Vitiligo: Emerging Clinical Trial Data and Safety Considerations

New Frontiers in CSCC: Experts Weigh Immunotherapy Options and Collaborative Referral Pathways

Previewing ​Dermatology Times ​Editorial Advisory Board Member ​Sessions at AAD 2023

Related Content

Referral Barriers Persist in Advanced Cutaneous Squamous Cell Carcinoma Care

Derm Dispatch: New ICD-10 Code Brings Validation to Patients With Topical Steroid Withdrawal

EADV Review Finds Major Safety and Transparency Gaps in Mobile AI Dermatology Apps

Switching from Biologics to Upadacitinib Yields Progressive Improvements in Moderate to Severe AD

How Dermatologists Can Incorporate GLP-1 Receptor Agonists Into Psoriasis Care

Latest CME

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Trending on Dermatology Times

Switching from Biologics to Upadacitinib Yields Progressive Improvements in Moderate to Severe AD

Real-World Study Finds Experienced Dermatologists Outperform AI in Skin Cancer Diagnosis

New Consensus Defines Remission, Disease Activity in Atopic Dermatitis

Systemic JAK Inhibitors for Vitiligo: Emerging Clinical Trial Data and Safety Considerations

New Frontiers in CSCC: Experts Weigh Immunotherapy Options and Collaborative Referral Pathways

Previewing Dermatology Times Editorial Advisory Board Member Sessions at AAD 2023